Literature DB >> 24277246

Studies on the mechanism of fluoropyrimidine cytotoxicity in l1210 cells: correlation with inhibition of thymidylate synthetase but not with incorporation into RNA.

K D Danenberg1, D Becker, M A Mulkins, P V Danenberg.   

Abstract

The effects of 5-fluorouracil (FUra), 5-fluorouridine (FUrd), and 5-fluoro-2'-deoxyuridine (FdUrd) on L1210 cells were examined in an effort to determine whether the cytotoxicity of these fluoropyrimidines is more closely associated with incorporation of FUra residues into RNA or inhibition of thymidylate (dTMP) synthetase (5,10-methylenetetrahydrofolate: deoxyuridylate C-methyl-transferase, EC 2.1.2.45) by 5-fluoro-2'-deoxyuridylate (FdUMP). In different batches of cells exposed to equitoxic (LD50) doses of these drugs for 48 hr, the levels of free FdUMP, dUMP, and free dTMP synthetase were found to be very similar. However, the number of FUra residues incorporated into total cellular RNA were in the approximate ratio of 1:10:100 in cells treated with FdUrd, FUrd, and FUra, respectively. Although these results are consistent with a common DNA-directed mechanism of toxicity, thymidine (dThd), which should circumvent dTMP synthetase inhibition, did not rescue the cells from the effects of FUra. However, uridine (Urd), which should compete with FUra for incorporation into RNA, had no effect on the toxicity of FUra either. Urd at 10(-5) M did not decrease the amount of incorporation of 10(-7)M [(3)H]FUra into total RNA, but a limited fractionation of polysomal RNA showed about a 4-fold decrease of incorporation of FUra into mRNA in the presence of Urd. Urd and dThd did effectively decrease the cytotoxicity of FUrd and FdUrd, respectively. These observations suggest that cell rescue experiments may not be reliable indicators of the mechanism of cytotoxicity of antimetabolites with complex mechanisms of action.

Entities:  

Year:  1984        PMID: 24277246     DOI: 10.1023/A:1016371802607

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  26 in total

1.  Assay of intracellular free and macromolecular-bound metabolites of 5-fluorodeoxyuridine and 5-fluorouracil.

Authors:  W L Washtien; D V Santi
Journal:  Cancer Res       Date:  1979-09       Impact factor: 12.701

2.  THE MODE OF ACTION OF 5-FLUOROURACIL AND ITS DERIVATIVES.

Authors:  S S Cohen; J G Flaks; H D Barner; M R Loeb; J Lichtenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1958-10-15       Impact factor: 11.205

3.  Characterization of poly(riboadenylic acid) segments in L-cell messenger ribonucleic acid.

Authors:  J J Eiden; J L Nichols
Journal:  Biochemistry       Date:  1973-09-25       Impact factor: 3.162

4.  Interaction of drugs inhibiting different steps in the synthesis of DNA.

Authors:  G B Grindey; C A Nichol
Journal:  Cancer Res       Date:  1972-03       Impact factor: 12.701

5.  Isolation of mRNA from KB-cells by affinity chromatography on polyuridylic acid covalently linked to Sepharose.

Authors:  U Lindberg; T Persson
Journal:  Eur J Biochem       Date:  1972-12-04

Review 6.  The pharmacology of the fluoropyrimidines.

Authors:  C E Myers
Journal:  Pharmacol Rev       Date:  1981-03       Impact factor: 25.468

7.  Potentiation of the anti-tumor activity of 5FU by thymidine and its correlation with the formation of (5FU)RNA.

Authors:  S Spiegelman; R Nayak; R Sawyer; R Stolfi; D Martin
Journal:  Cancer       Date:  1980-03-15       Impact factor: 6.860

8.  Catalytic function of thymidylate synthase is confined to S phase due to its association with replitase.

Authors:  G Prem veer Reddy
Journal:  Biochem Biophys Res Commun       Date:  1982-12-15       Impact factor: 3.575

9.  Effect of 5-fluorouracil on the synthesis and translation of polyadenylic acid-containing RNA from regenerating rat liver.

Authors:  C K Carrico; R I Glazer
Journal:  Cancer Res       Date:  1979-09       Impact factor: 12.701

10.  Isolation of fluoropyrimidine-resistant murine leukemic cell lines by one-step mutation and selection.

Authors:  M A Mulkins; C Heidelberger
Journal:  Cancer Res       Date:  1982-03       Impact factor: 12.701

View more
  1 in total

1.  An optimized synthesis of 18F-labelled 5-fluorouracil and a reevaluation of its use as a prognostic agent.

Authors:  G W Visser; G C Gorree; B J Braakhuis; J D Herscheid
Journal:  Eur J Nucl Med       Date:  1989
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.